[Idiopathic hypertrophic pachymeningitis].
Lettau
M
M
Laible
M
M
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001706:Biopsy; D002557:Cerebrospinal Fluid Shunts; D002908:Chronic Disease; D003251:Constriction, Pathologic / Q000175:diagnosis / Q000209:etiology; D003348:Cortisone / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D004388:Dura Mater / Q000473:pathology / Q000601:surgery; D005500:Follow-Up Studies; D006801:Humans; D006984:Hypertrophy; D007091:Image Processing, Computer-Assisted; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008279:Magnetic Resonance Imaging; D008297:Male; D008581:Meningitis / Q000175:diagnosis* / Q000209:etiology / Q000601:surgery; D008727:Methotrexate / Q000627:therapeutic use; D054063:Superior Sagittal Sinus / Q000473:pathology / Q000601:surgery
D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D003348:Cortisone; D008727:Methotrexate